Is the routine use of local antibiotics in the management of periprosthetic joint infections justified?. Issue 1 (January 2023)

• Record Type: Journal Article
• Authors: Bourget-Murray, Jonathan; Azad, Marisa; Gofton, Wade; Abdelbary, Hesham; Garceau, Simon; Grammatopoulos, George
• Is Part Of: Hip international. Volume 33:Issue 1(2023)
• Page Start: 4
• Page End: 16
• Publication Date: 2023-01
• Subjects: Antibiotic-loaded cement -- calcium sulphate -- local antibiotic -- periprosthetic joint infection -- topical antibiotic; Hip joint -- Pathophysiology -- Periodicals; Hip joint -- Diseases -- Periodicals; Hip joint -- Surgery -- Periodicals; 617.581005
• DOI: 10.1177/11207000221139467
• Languages: English
• ISSNs: 1120-7000

Abstract

Periprosthetic joint infection (PJI) following total hip and total knee arthroplasty continues to be a leading cause of re-operation and revision arthroplasty. Not only is the treatment of PJI notoriously challenging, but success rates are variable. Regardless of the surgical strategy used, successful management of PJI requires a comprehensive surgical debridement focused at eradicating the underlying biofilm followed by appropriate antimicrobial therapy. Although systemic antimicrobial delivery continues to be a cornerstone in the treatment of PJI, many surgeons have started using local antibiotics to deliver higher concentrations of antibiotics directly into the vulnerable joint and adjacent soft tissues, which often have compromised vascularity. Available evidence on the use of topical powder, bone cement, and calcium sulphate carriers for local delivery of antibiotics during the initial treatment of PJI is limited to studies that are extremely heterogeneous. There is currently no level-1 evidence to support routinely using these products. Further, appropriately powered, prospective studies are needed to quantify the safety and efficacy of antibiotic-located calcium-sulphate carriers to justify their added costs. These products should not encourage surgeons to deviate from best practice guidelines, such as those recommended during the International Consensus Meeting on Musculoskeletal Infections.